The answer provided by
@Supermatt is laughable.
Valuing the Deloraine aquisition by the plant and equipment is like valuing a car by its rubber and steel.
Let's assume
@Supermatt iss genius and his calculation is correct, a hyperthetical projection of 100% write-off on the intangible value carried by the Delorine aquisition means a reduction of the stock value by $0.045 per share. And how much the SP has dropped? And Does the P/S improve overweight the hypo write-off？
BUB's SP is reflecting the PEST condition, but not Deloraine. The acquisition of the latter is evaluated by what it could enable BUB. It enables BUB to enter the Chinese market with a reliable, sufficient supply which helps to establish its market position in China.
(20min delay)